Medicine & Life Sciences
Adenosine A2 Receptor Agonists
100%
ATL 313
59%
Horses
59%
Lipopolysaccharides
53%
Monocytes
51%
Tumor Necrosis Factor-alpha
44%
Adenosine A2A Receptors
31%
ZM 241385
28%
Adenosine
27%
N-(4-acetylphenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)acetamide
23%
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
19%
Adenosine A2 Receptor Antagonists
17%
Purinergic P1 Receptor Agonists
16%
Purinergic P1 Receptors
14%
Adenosine A3 Receptor Agonists
9%
Adenosine-5'-(N-ethylcarboxamide)
8%
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
8%
Anti-Inflammatory Agents
8%
Purinergic P1 Receptor Antagonists
8%
Adenosine A1 Receptors
7%
Cytokines
7%
Colforsin
6%
Nucleosides
5%
Physiological Phenomena
5%
Adenylyl Cyclases
5%
Agriculture & Biology
tumor necrosis factors
83%
monocytes
65%
adenosine
64%
lipopolysaccharides
59%
agonists
57%
horses
51%
receptors
42%
antagonists
17%
production economics
11%
cytokines
6%